QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 co-diagnostics-expands-vector-control-customer-base-to-25-customers-across-15-us-states-following-an-installation-in-nevada-next-week

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company with a unique, ...

 hc-wainwright--co-reiterates-neutral-on-co-diagnostics-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) with a Neutral and maintains $2 price target.

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-2

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q1-2024-gaap-eps-031-misses-021-estimate-sales-467854k-miss-3050m-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0....

 co-diagnostics-inc-appoints-richard-abbott-as-president-concurrent-with-the-co-naming-david-nielsen-to-be-its-chief-operations-officer

Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, ...

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-25

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q4-2023-gaap-eps-050-misses-020-estimate-sales-3555m-miss-3625m-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0....

 earnings-scheduled-for-march-14-2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

 earnings-preview-co-diagnostics
Earnings Preview: Co-Diagnostics
03/13/2024 17:01:56

 hc-wainwright--co-reiterates-neutral-on-co-diagnostics-maintains-3-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) with a Neutral and maintains $3 price target.

 co-diagnostics-announced-that-it-submitted-its-co-dx-pcr-covid-19-test-with-co-dx-pcr-pro-instrument-for-review-by-the-fda-for-emergency-use-authorization

The Company's Emergency Use Authorization submission is for the new Co-Dx PCR Pro instrument and COVID-19 test kit, designe...

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-raises-price-target-to-3

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and raises the price target fr...